Triheptanoin 1g/kg/day (DrugBank: Triheptanoin)
9 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
2 | 筋萎縮性側索硬化症 | 0 |
8 | ハンチントン病 | 1 |
149 | 片側痙攣・片麻痺・てんかん症候群 | 0 |
156 | レット症候群 | 0 |
248 | グルコーストランスポーター1欠損症 | 0 |
256 | 筋型糖原病 | 0 |
257 | 肝型糖原病 | 0 |
317 | 三頭酵素欠損症 | 0 |
324 | メチルグルタコン酸尿症 | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01882062 (ClinicalTrials.gov) | May 2013 | 18/6/2013 | Proof of Concept of an Anaplerotic Study Using Brain Phosphorus Magnetic Resonance Spectroscopy in Huntington Disease | Huntington Disease | Drug: Triheptanoin 1g/kg/day | Institut National de la Santé Et de la Recherche Médicale, France | NULL | Completed | 18 Years | N/A | All | 10 | Phase 2 | France |